BridgeBio Pharma Inc logo

BridgeBio Pharma Inc

$ 10.37 +0.43 (+4.33%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 1.54B
Enterprise V:
$ 2.47B
Volume:
1.36M
Avg Vol (2M):
2.19M
Also Trade In:
Volume:
1.36M
Market Cap $:
1.54B
PE Ratio:
At Loss
Avg Vol (2-Month):
2.19M
Enterprise Value $:
2.47B
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology.
Name Current Vs Industry Vs History
Cash-To-Debt 0.42
Equity-to-Asset -1.19
Debt-to-Equity -1.67
Debt-to-EBITDA -3.85
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.94
Distress
Grey
Safe
Beneish M-Score -3.81
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -26.9
3-Year EPS without NRI Growth Rate -18.7
3-Year FCF Growth Rate -31.2
Name Current Vs Industry Vs History
5-Day RSI 51.3
9-Day RSI 48.56
14-Day RSI 48.7
6-1 Month Momentum % -7.28
12-1 Month Momentum % -78.93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.46
Quick Ratio 5.46
Cash Ratio 5.07
Days Sales Outstanding 4.88
Days Payable 941.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.1

Financials (Next Earnings Date:2022-11-04 Est.)

BBIO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BBIO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 90.67
EPS (TTM) ($) -3.49
Beta 0.62
Volatility % 95.3
14-Day RSI 48.7
14-Day ATR ($) 0.916613
20-Day SMA ($) 10.7845
12-1 Month Momentum % -78.93
52-Week Range ($) 4.98 - 53.57
Shares Outstanding (Mil) 148.25

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BridgeBio Pharma Inc Filings

Document Form Filing Date
No Filing Data

BridgeBio Pharma Inc Analysis

Share your research

Headlines

See More
No news.